Rafael Blesa - Sant Pau Memory Unit - Alzheimer Research - Barcelona

Rafael Blesa

Rafael Blesa GonzalezDr. Rafael Blesa obtained his medical degree from the Universitat Autònoma de Barcelona in 1975 and specialized in Neurology at Hospital de la Santa Creu i Sant Pau.

After completing his Ph.D. in Medicine at the Universitat de Barcelona (1989) he worked at the National Institute of Health in Bethesda, Maryland (USA) as an associate researcher in experimental therapies. He returned to Barcelona in 1993 where he directed the Alzheimer and Other Cognitive Disorders Unit at Hospital Clínic for 10 years. Since 2003, Dr Blesa has been the Director of the Neurology Department at Hospital de la Santa Creu i Sant Pau.

Dr. Rafael Blesa is the author of more than 30 book chapters and more than 170 scientific articles published in high impact national and international journals, and he has been the principal investigator of over 70 research projects and pharmacological studies in the field of Alzheimer’s disease. He is a member of prestigious medical and scientific societies that have awarded his scientific contributions in numerous occasions.

In his professional trajectory, he has combined clinical and research tasks with teaching activities as an associate professor of Neurology at Universitat de Barcelona and Universitat Autònoma de Barcelona, and he has directed and supervised numerous doctoral theses.

Currently, besides directing the Neurology Department, Dr. Rafael Blesa is the principal investigator of the advanced therapies research line within the Memory Unit.

Recent Publications

  1. [A study of the habits and food waste production of young university students]. Morata Verdugo, MP et al. Nutr Hosp 2020
    PMID:31973544

  2. Comparative study between two European inception cohorts of patients with early systemic lupus erythematosus. Prevete, I et al. Clin. Exp. Rheumatol. 2020
    PMID:31969225

  3. Serodiscordant patients with systemic sclerosis: when antibody does not correspond to skin involvement. Iniesta Arandia, N et al. Clin. Exp. Rheumatol. 2020
    PMID:31969223

  4. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. van der Lee, SJ et al. Acta Neuropathol. 2020
    PMID:31955222

  5. Performance Assessment of Software to Detect and Assist Prescribers with Antimicrobial Drug Interactions: Are all of them Created Equal?. Morte-Romea, E et al. Antibiotics (Basel) 2020
    PMID:31947911

  6. [Acute poisoning by chemical products: analysis of the first 15 years of the Spanish Toxic Surveillance System (SETv)]. González-Díaz, A et al. Rev. Esp. Salud Publica 2020
    PMID:31942868

  7. Comorbidity in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction. Cluster analysis of the RICA registry. Opportunities for improvement. Arévalo Lorido, JC et al. Rev Clin Esp 2020
    PMID:31932045

  8. Thorough analysis of a rapid spread tuberculosis outbreak by epidemiological and whole-genome sequencing. Comin, J et al. Infect. Genet. Evol. 2020
    PMID:31931260

  9. The DICA Endoscopic Classification for Diverticular Disease of the Colon Shows a Significant Interobserver Agreement among Community Endoscopists: an International Study. Tursi, A et al. J Gastrointestin Liver Dis 2020
    PMID:31930224

  10. International Consensus on Diverticulosis and Diverticular Disease. Statements from the 3rd International Symposium on Diverticular Disease. Tursi, A et al. J Gastrointestin Liver Dis 2020
    PMID:31930220

  11. Diagnosis and treatment of thyroid nodules in Spain. Results of a national survey. Gómez-Pérez, AM et al. Endocrinol Diabetes Nutr 2020
    PMID:31926931

  12. Interpretation of OCT and OCTA images from a histological approach: clinical and experimental implications. Cuenca, N et al. Prog Retin Eye Res 2020
    PMID:31911236

  13. The Evolving Microbiome from Pregnancy to Early Infancy: A Comprehensive Review. Mesa, MD et al. Nutrients 2020
    PMID:31906588

  14. SEOM clinical guidelines in hereditary breast and ovarian cancer (2019). González-Santiago, S et al. Clin Transl Oncol 2019
    PMID:31889241

  15. Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: A randomized clinical trial with long-term follow-up. Garcia-Arranz, M et al. Stem Cells Transl Med 2019
    PMID:31886629

Search PubMed